Your browser doesn't support javascript.
loading
First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA.
Ghinai, Isaac; McPherson, Tristan D; Hunter, Jennifer C; Kirking, Hannah L; Christiansen, Demian; Joshi, Kiran; Rubin, Rachel; Morales-Estrada, Shirley; Black, Stephanie R; Pacilli, Massimo; Fricchione, Marielle J; Chugh, Rashmi K; Walblay, Kelly A; Ahmed, N Seema; Stoecker, William C; Hasan, Nausheen F; Burdsall, Deborah P; Reese, Heather E; Wallace, Megan; Wang, Chen; Moeller, Darcie; Korpics, Jacqueline; Novosad, Shannon A; Benowitz, Isaac; Jacobs, Max W; Dasari, Vishal S; Patel, Megan T; Kauerauf, Judy; Charles, E Matt; Ezike, Ngozi O; Chu, Victoria; Midgley, Claire M; Rolfes, Melissa A; Gerber, Susan I; Lu, Xiaoyan; Lindstrom, Stephen; Verani, Jennifer R; Layden, Jennifer E.
Afiliação
  • Ghinai I; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA; Illinois Department of Public Health, Springfield, IL, USA.
  • McPherson TD; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA; Chicago Department of Public Health, Chicago, IL, USA. Electronic address: oko9@cdc.gov.
  • Hunter JC; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Kirking HL; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Christiansen D; Cook County Department of Public Health, Oak Forest, IL, USA.
  • Joshi K; Cook County Department of Public Health, Oak Forest, IL, USA.
  • Rubin R; Cook County Department of Public Health, Oak Forest, IL, USA.
  • Morales-Estrada S; Cook County Department of Public Health, Oak Forest, IL, USA.
  • Black SR; Chicago Department of Public Health, Chicago, IL, USA.
  • Pacilli M; Chicago Department of Public Health, Chicago, IL, USA.
  • Fricchione MJ; Chicago Department of Public Health, Chicago, IL, USA.
  • Chugh RK; DuPage County Health Department, Wheaton, IL, USA.
  • Walblay KA; Chicago Department of Public Health, Chicago, IL, USA.
  • Ahmed NS; Metro Infectious Disease Consultants, Burr Ridge, IL, USA.
  • Stoecker WC; Metro Infectious Disease Consultants, Burr Ridge, IL, USA.
  • Hasan NF; Premier Primary Care Physicians, Carol Stream, IL, USA.
  • Burdsall DP; Illinois Department of Public Health, Springfield, IL, USA.
  • Reese HE; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Wallace M; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Wang C; Cook County Health, Chicago, IL, USA; Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
  • Moeller D; Cook County Health, Chicago, IL, USA; Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
  • Korpics J; Cook County Health, Chicago, IL, USA; Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
  • Novosad SA; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Benowitz I; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Jacobs MW; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA; Lake Erie College of Osteopathic Medicine, Erie, PA, USA.
  • Dasari VS; One Health Office, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA; Boonshoft School of Medicine, Wright State University, Dayton, OH, USA.
  • Patel MT; Illinois Department of Public Health, Springfield, IL, USA.
  • Kauerauf J; Illinois Department of Public Health, Springfield, IL, USA.
  • Charles EM; Illinois Department of Public Health, Springfield, IL, USA.
  • Ezike NO; Illinois Department of Public Health, Springfield, IL, USA.
  • Chu V; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Midgley CM; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Rolfes MA; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Gerber SI; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Lu X; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Lindstrom S; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Verani JR; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Layden JE; Chicago Department of Public Health, Chicago, IL, USA. Electronic address: jennifer.layden@cityofchicago.org.
Lancet ; 395(10230): 1137-1144, 2020 04 04.
Article em En | MEDLINE | ID: mdl-32178768
BACKGROUND: Coronavirus disease 2019 (COVID-19) is a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first detected in China in December, 2019. In January, 2020, state, local, and federal public health agencies investigated the first case of COVID-19 in Illinois, USA. METHODS: Patients with confirmed COVID-19 were defined as those with a positive SARS-CoV-2 test. Contacts were people with exposure to a patient with COVID-19 on or after the patient's symptom onset date. Contacts underwent active symptom monitoring for 14 days following their last exposure. Contacts who developed fever, cough, or shortness of breath became persons under investigation and were tested for SARS-CoV-2. A convenience sample of 32 asymptomatic health-care personnel contacts were also tested. FINDINGS: Patient 1-a woman in her 60s-returned from China in mid-January, 2020. One week later, she was hospitalised with pneumonia and tested positive for SARS-CoV-2. Her husband (Patient 2) did not travel but had frequent close contact with his wife. He was admitted 8 days later and tested positive for SARS-CoV-2. Overall, 372 contacts of both cases were identified; 347 underwent active symptom monitoring, including 152 community contacts and 195 health-care personnel. Of monitored contacts, 43 became persons under investigation, in addition to Patient 2. These 43 persons under investigation and all 32 asymptomatic health-care personnel tested negative for SARS-CoV-2. INTERPRETATION: Person-to-person transmission of SARS-CoV-2 occurred between two people with prolonged, unprotected exposure while Patient 1 was symptomatic. Despite active symptom monitoring and testing of symptomatic and some asymptomatic contacts, no further transmission was detected. FUNDING: None.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Infecções por Coronavirus / Betacoronavirus Tipo de estudo: Prognostic_studies Limite: Female / Humans / Middle aged País/Região como assunto: America do norte / Asia Idioma: En Revista: Lancet Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Infecções por Coronavirus / Betacoronavirus Tipo de estudo: Prognostic_studies Limite: Female / Humans / Middle aged País/Região como assunto: America do norte / Asia Idioma: En Revista: Lancet Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos